Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review
MetadataShow full item record
© Authors. Published by MDPI Publishing.
Some random mutations can confer a selective advantage to a hematopoietic stem cell. As a result, mutated hematopoietic stem cells can give rise to a significant proportion of mutated clones of blood cells. This event is known as “clonal hematopoiesis.” Clonal hematopoiesis is closely associated with age, and carriers show an increased risk of developing blood cancers. Clonal hematopoiesis of indeterminate potential is defined by the presence of clones carrying a mutation associated with a blood neoplasm without obvious hematological malignancies. Unexpectedly, in recent years, it has emerged that clonal hematopoiesis of indeterminate potential carriers also have an increased risk of developing cardiovascular disease. Mechanisms linking clonal hematopoiesis of indeterminate potential to cardiovascular disease are only partially known. Findings in animal models indicate that clonal hematopoiesis of indeterminate potential-related mutations amplify inflammatory responses. Consistently, clinical studies have revealed that clonal hematopoiesis of indeterminate potential carriers display increased levels of inflammatory markers. In this review, we describe progress in our understanding of clonal hematopoiesis in the context of cancer, and we discuss the most recent findings linking clonal hematopoiesis of indeterminate potential and cardiovascular diseases.
Showing items related by title, author, creator and subject.
Shah, S.; Roth, A.; Goya, R.; Oloumi, A.; Ha, G.; Zhao, Y.; Turashvili, G.; Ding, J.; Tse, K.; Haffari, G.; Bashashati, A.; Prentice, L.; Khattra, J.; Burleigh, A.; Yap, D.; Bernard, V.; McPherson, A.; Shumansky, K.; Crisan, A.; Giuliany, R.; Heravi-Moussavi, A.; Rosner, J.; Lai, D.; Birol, I.; Varhol, Richard; Tam, A.; Dhalla, N.; Zeng, T.; Ma, K.; Chan, S.; Griffith, M.; Moradian, A.; Cheng, S.; Morin, G.; Watson, P.; Gelmon, K.; Chia, S.; Chin, S.; Curtis, C.; Rueda, O.; Pharoah, P.; Damaraju, S.; MacKey, J.; Hoon, K.; Harkins, T.; Tadigotla, V.; Sigaroudinia, M.; Gascard, P.; Tlsty, T.; Costello, J.; Meyer, I.; Eaves, C.; Wasserman, W.; Jones, S.; Huntsman, D.; Hirst, M.; Caldas, C.; Marra, M.; Aparicio, S. (2012)Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor, progesterone receptor and ERBB2 gene amplification, represent approximately 16% of all breast cancers. Here we show in ...
Effectiveness of general practice nurse interventions in cardiac risk factor reduction amongst adultsHalcomb, E.; Moujalli, S.; Griffiths, R.; Davidson, Patricia (2007)Background: Cardiovascular disease is the leading cause of death for adults in Australia. In recent years there has been a shift in health service delivery from institutional to community-based care for chronic conditions, ...
Kasaian, K.; Wiseman, S.; Thiessen, N.; Mungall, K.; Corbett, R.; Qian, J.; Nip, K.; He, A.; Tse, K.; Chuah, E.; Varhol, Richard; Pandoh, P.; McDonald, H.; Zeng, T.; Tam, A.; Schein, J.; Birol, I.; Mungall, A.; Moore, R.; Zhao, Y.; Hirst, M.; Marra, M.; Walker, B.; Jones, S. (2013)Parathyroid carcinoma is a rare endocrine malignancy with an estimated incidence of less than 1 per million population. Excessive secretion of parathyroid hormone, extremely high serum calcium level, and the deleterious ...